A new face of endocannabinoids in pharmacotherapy. Part II: Role of endocannabinoids in inflammation-derived cardiovascular diseases infarction

• Autorzy: Zubrzycki M. , Liebold A. , Janecka A. , Zubrzycka M.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

endocannabinoid system; anandamide; pharmacotherapy; cardiovascular system; restenosis; cardiomyopathy; inflammatory disorder; hepatic cirrhosis; ischaemic heart disease; atherosclerosis

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2014
• Tom: 65
• Numer: 2
• Opis fizyczny: p.183-191,fig.,ref.

Twórcy

autor

Zubrzycki M.

• Department of Cardiovascular and Thoracic Surgery, University of Ulm, Albert Einstein Allee 23, D- 89081 Ulm, Germany

autor

Liebold A.

• Department of Cardiovascular and Thoracic Surgery, University of Ulm, Ulm, Germany

autor

Janecka A.

• Department of Biomolecular Chemistry, Medical University of Lodz, Lodz, Poland

autor

Zubrzycka M.

• Department of Experimental Physiology, Chair of Experimental and Clinical Physiology, Medical University of Lodz, Lodz, Poland